← Back to Search

Early Intervention for Pain Management in Cancer

N/A
Waitlist Available
Led By Andrea Enzinger, MD
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of a metastatic, or locally advanced unresectable malignancy
Anticipated prognosis of more than 6 months according to the primary oncologist
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks up to 4 months
Awards & highlights

Study Summary

This trial will test whether referring patients with cancer pain to a pain management specialist is feasible and helpful.

Who is the study for?
This trial is for adults over 21 with advanced or metastatic cancer, experiencing persistent pain rated at least a 4 out of 10. They should expect to live more than six months and have pain from cancer or its treatment. It's not for those with neuropathy, high opioid use, prior specialized pain care, bleeding risks, infections that can't be controlled, history of opioid misuse, or cognitive impairments.Check my eligibility
What is being tested?
The study tests the effectiveness of early referral to a pain specialist for managing cancer-related pain using various strategies and procedures designed to alleviate discomfort. The goal is to see if this approach helps patients better manage their cancer-associated pain.See study design
What are the potential side effects?
While specific side effects are not detailed here as it depends on the individualized interventions by the pain specialist, potential side effects may include discomfort from procedures used to manage pain and reactions related to any medications prescribed.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have been diagnosed with a cancer that has spread to other parts of the body or is not able to be surgically removed.
Select...
Your doctor expects you to live for at least 6 more months.
Select...
You are older than 21 years.
Select...
You have ongoing pain that you rate as a 4 or higher on a scale from 0 to 10.
Select...
You have been in pain for at least 2 weeks.
Select...
You are experiencing pain because of cancer or past cancer treatments.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks up to 4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks up to 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain Care Participation Rate
Pain Consultation Participation Rate
Satisfaction Ratings

Trial Design

1Treatment groups
Experimental Treatment
Group I: Pain management strategiesExperimental Treatment2 Interventions
Participants will receive early referral to an anesthesia-trained interventional pain management specialist evaluated for pain management strategies. Participants will complete surveys every 2 months and will have the option of tracking their pain at home using a secure smartphone application. Participants will be followed on the study for 4 months.

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor
1,072 Previous Clinical Trials
340,376 Total Patients Enrolled
1 Trials studying Cancer Pain
54 Patients Enrolled for Cancer Pain
MedtronicIndustry Sponsor
605 Previous Clinical Trials
828,281 Total Patients Enrolled
Andrea Enzinger, MDPrincipal InvestigatorDana-Farber Cancer Institute
4 Previous Clinical Trials
319 Total Patients Enrolled

Media Library

Early Referral Clinical Trial Eligibility Overview. Trial Name: NCT05366413 — N/A
Cancer Pain Research Study Groups: Pain management strategies
Cancer Pain Clinical Trial 2023: Early Referral Highlights & Side Effects. Trial Name: NCT05366413 — N/A
Early Referral 2023 Treatment Timeline for Medical Study. Trial Name: NCT05366413 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities currently available to participate in this clinical trial?

"Clinicaltrials.gov indicates that this medical trial is not presently recruiting patients, as the listing was first posted on October 1st 2022 and last edited May 4th 2022. However, there are 36 other trials actively seeking candidates right now."

Answered by AI
~11 spots leftby Mar 2025